国家: 以色列
语言: 英文
来源: Ministry of Health
OMEPRAZOLE
DEXCEL LTD, ISRAEL
A02BC01
CAPLETS
OMEPRAZOLE 40 MG
PER OS
Required
DEXCEL LTD, ISRAEL
OMEPRAZOLE
OMEPRAZOLE
Acute duodenal ulcer. Acute gastric ulcer. Reflux esophagitis: treatment , long - term management. Maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. Maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. Zollinger-Ellison Syndrome. Treatment and prevention of NSAID-associated duodenal and gastric ulcers or erosions in high risk patients. Treatment of severe reflux oesophagitis in children overthe age of 6 year.Helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.
2020-10-31
PATIENT PACKAGE INSERT ACCORDING TO PHARMACISTS' REGULATIONS (PREPARATIONS) – 1986 This medicine can be sold with a physician’s prescription only OMEPRADEX ® , CAPLETS, 10, 20, 40 MG Each caplet contains: Omeprazole 10, 20, or 40 mg respectively. Inactive ingredients and allergens in the medicine - see section 6 "Additional information" and in section 2 "Important information about some of the ingredients of the medicine". READ THIS ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have any further questions, ask the doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if you think that their medical condition is the same as yours. THIS MEDICINE IS INTENDED FOR USE IN CHILDREN OVER 6 YEARS OF AGE. 1. WHAT IS THE MEDICINE INTENDED FOR? The medicine inhibits acid secretion in the gastrointestinal tract. This medicine is intended for: Treatment of gastric ulcer and duodenal ulcer. Combination treatment with antibiotics for Helicobacter pylori associated with gastrointestinal ulcer. Treatment of inflammation of the esophagus due to reflux (reflux esophagitis). Long-term treatment of reflux esophagitis. Treatment of Zollinger-Ellison Syndrome. Maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer or severe reflux esophagitis. Treatment of severe reflux esophagitis in children over 6 years of age. Treatment and prevention of gastric ulcer or duodenal ulcer caused by treatment with NSAIDs (non-steroidal anti-inflammatory drugs) in high risk patients. THERAPEUTIC GROUP: Proton pump inhibitors (PPIs). 2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE IF: You are hypersensitive (allergic) to the active ingredient (omeprazole) or to any of the other ingredients this medicine contains (see section 6). You are hypersensitive (allergic) to medicines that contain other proton pump inhibitors (PPI) (e.g. 阅读完整的文件